A robotic spine exoskeleton based on linear electric actuators for spinal deformity correction
Vibroengineering Procedia · 16.07.2026 · 63 · 76-81
DOI: 10.21595/vp.2026.26475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vibroengineering Procedia, online erschienen am 16.07.2026. Verfasst von Ulpan Tassybayeva und 4 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This paper presents a conceptual design of a robotic exoskeleton for active correction of spinal deformities. Unlike existing support-based systems, the proposed approach is correction-oriented and uses a multi-segment structure with linear electric actuators. A comparative analysis of actuation systems was conducted, and the FOCOTECK LA14C actuator was selected for wearable application. The exoskeleton is designed as a vest-based system with actuators mounted via articulated joints to improve kinematic compatibility. A CAD model was developed to evaluate the feasibility of the design. Future work will include simulation and experimental validation using a 3D-printed prototype
Zitieren
APA
Tassybayeva, U., Orazaliyeva, S., Rakhmatillaev, J., Zhetenbayev, N., & Sergazin, G. (2026). A robotic spine exoskeleton based on linear electric actuators for spinal deformity correction. Vibroengineering Procedia, 63, 76-81. https://doi.org/10.21595/vp.2026.26475
Vancouver
Tassybayeva U, Orazaliyeva S, Rakhmatillaev J, Zhetenbayev N, Sergazin G. A robotic spine exoskeleton based on linear electric actuators for spinal deformity correction. Vibroengineering Procedia. 2026;63:76-81. doi:10.21595/vp.2026.26475
BibTeX
@article{Tassybayeva2026,
author = {Tassybayeva, Ulpan and Orazaliyeva, Sandugash and Rakhmatillaev, Javlonbek and Zhetenbayev, Nursultan and Sergazin, Gani},
title = {A robotic spine exoskeleton based on linear electric actuators for spinal deformity correction},
journal = {Vibroengineering Procedia},
year = {2026},
volume = {63},
pages = {76--81},
doi = {10.21595/vp.2026.26475}
}
EUVIMED